Start with the brand story. Find the technical opportunity.
Direct selling depends on a story that the field can understand, repeat and connect to a customer need. A proprietary ingredient program starts by identifying the part of your brand promise that deserves a tangible product expression. We review the existing portfolio, target consumer, ingredient landscape and commercial constraints before choosing the development direction.
Develop a meaningful variation.
The opportunity may be a novel delivery system, a differentiated ingredient variant, a defined material specification or an ingredient combination developed for a particular application. PCG helps connect the concept with sourcing and formulation feasibility. A new name alone is not a technical difference; the brief should explain what changes and why it matters to the product.
For example, a familiar ingredient could become the starting point for a delivery-system investigation, followed by a comparison plan and a branded ingredient identity. That is a development pathway, not a promise of enhanced absorption. Any performance claim must follow the evidence generated for the actual material and application.
Build the substantiation around the intended claims.
We identify the evidence already available, the gaps that matter and the specialist work needed to address them. The program can coordinate characterization, stability and compatibility work, research planning and studies appropriate to the proposed claims. Material changes can create new safety and regulatory questions, which are evaluated for the intended market with qualified partners.
Research is separately scoped at market rates. The study design should answer a useful commercial question, and the resulting claims must reflect the findings rather than the initial aspiration.
Give the ingredient an identity the field can use.
Connect naming, positioning, the technical story and product applications in one coherent ingredient platform. The scope can include a clear explanation of what the ingredient is, what differentiates it and which statements the evidence supports. Build distributor education and brand materials around that same foundation, with specialist review of claims and trademark clearance where required.
Design for long-term ownership and continuity.
Agree the asset map before development begins: specifications, new know-how, research data and usage rights, branding work, supply arrangements and any potential filings. Separate client-owned project work from existing technology and third-party licenses. Define exclusivity, permitted applications, territories, access to records and what happens if a supplier or manufacturing partner changes.
The commercial goal is a defensible advantage that can grow with the brand. A recognizable identity, relevant evidence, controlled know-how and clear contracts can contribute to that advantage. Patentability, freedom to operate and enforceable protection require assessment by qualified IP counsel.
Protection has different lifetimes: see the USPTO’s guidance on patent terms, maintaining trademarks, and trade secrets.
A team built around the full journey.
Over 1,500 product engagements since 2011. Selected team experience includes collaboration with a leading ingredient supplier on a bioavailability enhancer later commercialized as an ingredient innovation.
Explore our anonymous ingredient experience ↗Proprietary ingredient development: your questions.
What is a proprietary ingredient program for a direct-selling company?
It is a coordinated development engagement that connects a differentiated ingredient or delivery approach with specifications, evidence, naming, commercial rights and product applications. The objective is an ingredient story the brand can develop into a durable business asset.
Can we start with an existing ingredient?
Yes. PCG can explore a new delivery approach, material specification, ingredient variant or formulation system around an existing ingredient. Technical feasibility, safety, regulatory status and third-party rights need evaluation; a variation is not automatically patentable or commercially superior.
Will our company own the ingredient and supporting work?
The program can be structured around client ownership of defined project assets, with assignments or licenses documented before work begins. The agreement should distinguish newly created work from supplier technology, existing PCG know-how and other third-party rights. Exclusivity, territory, fields of use and continuing access are negotiated explicitly.
Can the intellectual property last forever?
Some brand assets can support long-term ownership, but protection differs by type. Patents have finite terms. Trademark rights and trade-secret protection can continue when their requirements are maintained. PCG coordinates development around the intended ownership strategy; qualified IP counsel assesses protection, clearance and enforceability.
What substantiation and branding can the program include?
The scope can include an evidence review, a research plan, study coordination, ingredient naming and positioning, and materials that explain the ingredient accurately. Required work is determined by the actual material, intended market and proposed claims. Research results and legal protection cannot be guaranteed.
How does the engagement work commercially?
PCG can undertake a defined contract-development project or a broader proprietary ingredient program. Development and portfolio work are fee-based below $50 million in annual revenue and can be fee-free to clients above that threshold through agreed CDMO compensation. Contract research is separately scoped at market rates. IP, third-party testing and specialist costs are addressed in the project scope; companies at exactly $50 million should contact PCG.